Onera Health

Onera has recently obtained the CE marking for its first product, an innovative polysomnography (PSG) system that allows sleep disorders to be diagnosed from the patient's home, with the same gold-standard quality as a diagnostic system in a hospital.

Onera will use the funding to carry out clinical studies and further commercialise its sleep diagnostics and monitoring products in Europe and the United States.

Through this investment, Invest-NL contributes to improving the quality of life for patients with sleep disorders and reducing healthcare costs.